The Driven Brands Collision Group, the parent company of leading collision repair brands including Abra,CARSTAR, and Fix Auto USA announced that it has surpassed $6 million raised for cystic fibrosis ...
Here are the top 5 most-read pulmonary fibrosis articles of 2025.
Leisure-time physical activity appears to protect against advanced fibrosis in patients with MASLD and MetALD, a new study shows.
Just two months after reviving its prowess in the idiopathic pulmonary fibrosis (IPF) treatment area with rare lung disease med Jascayd, Boehringer Ingelheim is already unlocking another patient po | ...
The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.
The FDA has approved Jascayd (nerandomilast) as a treatment for a second lung disease, progressive pulmonary fibrosis, following the drug’s initial approval in October 2025 as a treatment for ...
Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that differs from person to person. An autosomal recessive disorder ...
On October 3, 2025, a multicenter team from Shenzhen University, Xiangya Hospital of Central South University, Zhujiang Hospital of Southern Medical ...
People in Lexington got a chance to experience an elaborate holiday display Sunday while supporting a good cause.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback